Periprocedural Bridging Anticoagulation: Measuring the Impact of a Clinical Trial on Care Delivery | |
Geoffrey D. Barnes; Yun Li; Xiaokui Gu; Brian Haymart; Eva Kline-Rogers; Steven Almany; Jay Kozlowski; Gregory Krol; Michael McNamara; James B. Froehlich | |
刊名 | The American Journal of Medicine |
2019 | |
卷号 | Vol.132 No.1页码:109(e1-e7) |
关键词 | Anticoagulation Evidence-based practice Heparin Low molecular weight Perioperative Warfarin |
ISSN号 | 0002-9343 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4604186 |
专题 | 湖南大学 |
作者单位 | 1.b School of Public Health, University of Michigan, Ann Arbor a Frankel Cardiovascular Center f Spectrum Health, Grand Rapids, Mich 2.Henry Ford Health System, Detroit, Mich 3.Huron Valley Sinai Hospital, Commerce Township, Mich 4.Beaumont Health/Oakland University School of Medicine, Royal Oak, Mich |
推荐引用方式 GB/T 7714 | Geoffrey D. Barnes,Yun Li,Xiaokui Gu,et al. Periprocedural Bridging Anticoagulation: Measuring the Impact of a Clinical Trial on Care Delivery[J]. The American Journal of Medicine,2019,Vol.132 No.1:109(e1-e7). |
APA | Geoffrey D. Barnes.,Yun Li.,Xiaokui Gu.,Brian Haymart.,Eva Kline-Rogers.,...&Scott Kaatz.(2019).Periprocedural Bridging Anticoagulation: Measuring the Impact of a Clinical Trial on Care Delivery.The American Journal of Medicine,Vol.132 No.1,109(e1-e7). |
MLA | Geoffrey D. Barnes,et al."Periprocedural Bridging Anticoagulation: Measuring the Impact of a Clinical Trial on Care Delivery".The American Journal of Medicine Vol.132 No.1(2019):109(e1-e7). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论